Skip to main content

Trading With Your Brain--And Your Gut


It's been said that many traders who claim to trade based on intuition are actually more into wishin'.  The gut can be used as a great excuse for not using the brain.  The reality is that the gut and brain can act in harmony, and it is the trading plan that accomplishes this synthesis.

A good example can be found in the current stock market.  If you've been following my trading notes, you know that I've been highlighting the vigor of the recent market.  Following February's lows, which saw considerably fewer stocks making new lows relative to the January bottom, the launch has been strong.  Indeed, as of Friday's close, we had over 90% of SPX stocks close above their 3, 5, 10, and 20-day moving averages and almost as many above their 50-day averages.  Only a handful of days in the past ten years have displayed such broad strength.  

So during this vigorous rise, my plan has been to be a buyer of weakness.  That's the brain, the head, the analysis:  I've looked at past market cycles and the behavior of momentum early in the bull phase of those cycles and know that strength has tended to beget further strength.  The plan provides my strategy.

But when will this weakness materialize?  I have no f*cking clue.  But I'll know it when I see it--that's the role of the gut.

In yesterday's trade, we had already traded considerably higher in overnight hours, so I wanted to be a buyer of intraday weakness.  When early selling could not take us to meaningfully negative readings on the uptick/downtick measures I follow and could not keep us beneath the session's opening price, I became a buyer.  I acted on my strategy with tactics--the gut provided those tactics, identifying that we were getting sellers and sellers could not move the market.

Differentiating strategy from tactics helps a trader figure out his or her mistakes.  If you've been a bear during the recent market period and losing as a result, your problem has been one of strategy.  Whatever has led you to your directional stance has been wrong.  It's a problem of the brain, a flaw of analysis.

On the other hand, if you've had market direction correct but implemented your trades unsuccessfully, that's a problem of tactics.  Your gut is failing you.  That happened to me this past week when I bought weakness following the breakdown of trade on Thursday (the reversal of the ECB impact) and bought too early.  The market continued meaningfully lower and I stopped out with a loss.  In my review, I saw clearly that I had identified when there was weakness, but did not wait for that weakness to dry up.  I was too eager to buy and never waited for that gut sense that sellers could no longer push the market lower.

That failure of the gut often occurs when we become so focused on the plan that we stop listening to our experience.  It's equally problematic when we trade our feel and fail to plan.  We might pick up a short-term pattern, only to be run over by what is occurring in the larger picture.  I've found it helpful to do all my planning before the market open and then stay open to experience during the trading session.  Failure comes from lack of preparation before the open (not feeding the brain) and staying too plan focused during the trading day (overriding the gut).

One of the great challenges of discretionary trading is that we have two information processing systems operating at all times: one intellectual, one intuitive.  Trading with half a brain is the surest way to trade half-assed.

Further Reading:  Paying the Tuition for Your Intuition
.

Comments

Post a Comment

Popular posts from this blog

Austerity-A Fancy Word for Destitute.

The reason for this post is not for the folks who have been caught in the first wave of personal economic hard reality, but the next wave. Regardless of the optimism espoused by grinning leaders and sycophant press, we are entering the final stage of global economic collapse. It began in 2008 and was forestalled for five years with fudge putty, but the weight of global indebtedness cannot be propped any longer and the final crunch is imminent. Austerity measures herald the final throes.  Indications of coming austerity.   Austerity measures are the final last ditch effort, futile or not! Back in the day many of us old-timers went through periods of "hard-times". In retrospect I realize there is no comparison to yesteryear hard times and today's version. Back then, expectations were never very high for the working class, there were no sophisticated systems or conveniences anyway. In fact the difference between being "set" or not was about having treats or not. Si...
Post a Comment
Read more

Terrifying Arctic methane levels

A peak methane level of 3026 ppb was recorded by the MetOp-B satellite at 469 mb on December 11, 2021 am. This follows a peak methane level of  3644 ppb  recorded by the MetOp-B satellite at 367 mb on November 21, 2021, pm. A peak methane level of 2716 ppb was recorded by the MetOp-B satellite at 586 mb on December 11, 2021, pm, as above image shows. This image is possibly even more terrifying than the image at the top, as above image shows that at 586 mb, i.e. much closer to sea level, almost all methane shows up over sea, rather than over land, supporting the possibility of large methane eruptions from the seafloor, especially in the Arctic.  Also, the image was recorded later than the image at the top with the 3026 ppb peak, indicating that even more methane may be on the way. This appears to be confirmed by the Copernicus forecast for December 12, 2021, 03 UTC, as illustrated by the image below, which shows methane at 500 hPa (equivalent to 500 mb). Furthermore, ...
Post a Comment
Read more

Women and children overboard

It's the  Catch-22  of clinical trials: to protect pregnant women and children from the risks of untested drugs....we don't test drugs adequately for them. In the last few decades , we've been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for "vulnerable populations,"  like pregnant women and children, the default was to exclude them. And just in case any women might be, or might become, pregnant, it was often easier just to exclude us all from trials. It got so bad, that by the late 1990s, the FDA realized regulations and more for pregnant women - and women generally - had to change. The NIH (National Institutes of Health) took action too. And so few drugs had enough safety and efficacy information for children that, even in official circles, children were being called "therapeutic orphans."  Action began on that, too. There is still a long way to go. But this month there was a sign that ...
Post a Comment
Read more